2018
DOI: 10.1161/atvbaha.117.309524
|View full text |Cite
|
Sign up to set email alerts
|

Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies—Statement From ATVB Council

Abstract: Abstract-There are many differences in arterial diseases between men and women, including prevalence, clinical manifestations, treatments, and prognosis. The new policy of the National Institutes of Health, which requires the inclusion of sex as a biological variable for preclinical studies, aims to foster new mechanistic insights and to enhance our understanding of sex differences in human diseases. The purpose of this statement is to suggest guidelines for designing and reporting sex as a biological variable… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
136
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 230 publications
(141 citation statements)
references
References 142 publications
4
136
1
Order By: Relevance
“…First, we compared the size of lesions (plaques; revealed by Oil red O staining) in aortic root cross sections prepared from the two groups of mice (KO and control). Prior studies using the mouse model of HFD‐induced atherosclerosis on the C57BL/6 ApoE −/− background showed differences in the disease susceptibilities between males and females 20,21 . However, in our work, differences between the control and L13a KO mice on the C57BL/6 ApoE −/− background with HFD treatment were equivalent for both genders 11 .…”
Section: Resultscontrasting
confidence: 59%
“…First, we compared the size of lesions (plaques; revealed by Oil red O staining) in aortic root cross sections prepared from the two groups of mice (KO and control). Prior studies using the mouse model of HFD‐induced atherosclerosis on the C57BL/6 ApoE −/− background showed differences in the disease susceptibilities between males and females 20,21 . However, in our work, differences between the control and L13a KO mice on the C57BL/6 ApoE −/− background with HFD treatment were equivalent for both genders 11 .…”
Section: Resultscontrasting
confidence: 59%
“…In this mouse model, suprarenal AAAs form in up to 80–85% of the cases. As indicated in Robinet et al., there is a low AAA incidence in Ang II infused female ApoE −/− mice (∼20%), therefore we chose to study male ApoE −/− mice that have between 80 and 100% AAA incidence [ 7 ]. Both sex hormones [ 8 ] and sex chromosomes [ 9 ] have been shown to effect AAA development in experimental AAA.…”
Section: Methodsmentioning
confidence: 99%
“…Early population-based estimates of PAD prevalence in women have been plagued by methodological difficulties, including the use of intermittent claudication as the basis for disease categorization and failure to account for mean height differences between men and women when determining normal ABI values. 90 The prevalence of PAD increases with age for both men and women; however, when calculating the "burden" of disease by age and sex from US census data, there are more women than men with PAD among US adults ≥40 years of age. 91 Contemporary reviews now estimate that the global prevalence of PAD is higher in women than in men, 92 and the increase in mortality and disability associated with PAD worldwide has been greater among women than men.…”
Section: Opportunities To Identify Differences Related To Sex and Ethmentioning
confidence: 99%